Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 4, 2007, Pages 409-413

  Davis, Michael K ^a   Andres, Joel M ^a   Jolley, Christopher D ^a   Novak, Donald A ^a   Haafiz, Allah B ^a   González Peralta, Regino P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Anti Saccharomyces cerevisiae antibodies; Crohn disease; Escherichia coli outer membrane porin C; Ulcerative colitis

Indexed keywords

BACTERIUM ANTIBODY; MEMBRANE PROTEIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PORIN; PORIN C; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CROHN DISEASE; DISEASE MARKER; ENDOSCOPY; ESCHERICHIA COLI; FEMALE; HISTOLOGY; HUMAN; MALE; PREDICTION AND FORECASTING; PRIORITY JOURNAL; RADIOGRAPHY; RETROSPECTIVE STUDY; SACCHAROMYCES CEREVISIAE; SERODIAGNOSIS; ULCERATIVE COLITIS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, BACTERIAL; BARIUM SULFATE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; PORINS; PREDICTIVE VALUE OF TESTS; RADIOGRAPHY, ABDOMINAL; RETROSPECTIVE STUDIES; SACCHAROMYCES CEREVISIAE; TOMOGRAPHY, X-RAY COMPUTED;

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

EID: 37349078672     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31812f7f6e     Document Type: Article

References (7)

1. Sands BE. Crohn's disease. In: Feldman M, Friedman LS, Sleisenger MH (eds). Sleisenger & Fordtran's Gastrointestinal and Liver Disease,7th ed. Philadelphia: WB Saunders; 2002. pp. 2005-38.
2. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology 2002;123:689-99.
3. Zholudev A, Zurakowski D, Young W, et al. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol 2004;99:2235-41.
4. Austin GL, Shaheen NJ, Sandler RS. Positive and negative predictive values: use of inflammatory bowel disease serologic markers. Am J Gastroenterol 2006;101:413-6.
5. Sabery N, Bass D. Use of serologic markers as a screening tool in inflammatory bowel disease compared with elevated erythrocyte sedimentation rate and anemia. Pediatrics 2007;119:e193-9.
6. Dubinsky MC, Ofman JJ, Urman M, et al. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2001;96:758-65.
7. Dubinsky MC, Lin YC, Dutridge D, et al. Serum immune responses predict rapid disease progression among children with Crohn's disease. Am J Gastroenterol 2006;101:360-7.